Medical News Today -
30 Oct 2013 11:00
Zohydro ER, a Schedule II controlled substance under the Controlled Substances Act, is the first FDA-approved single-entity (not combined with an analgesic such as acetaminophen) and extended-release hydrocodone product. Zohydro ER will offer prescribers an additional therapeutic option to treat pain, which is important because individual patients may respond differently to different opioids. Zohydro ER is in the class of extended-release/long-acting (ER/LA) opioid analgesics...
Share this Article